|
|
Volumn 332, Issue 7541, 2006, Pages 566-
|
|
Indian study sparks debate on the use of placebo in psychiatry trials.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEUROLEPTIC AGENT;
PLACEBO;
RISPERIDONE;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
BIPOLAR DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
INDIA;
MEDICAL ETHICS;
MENTAL HEALTH THERAPIES;
RANDOMIZED CONTROLLED TRIAL;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
MENTAL HEALTH THERAPIES;
ANTIPSYCHOTIC AGENTS;
BIPOLAR DISORDER;
ETHICS, MEDICAL;
HUMANS;
INDIA;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS;
RISPERIDONE;
|
|
EID: 33644955607
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.332.7541.566-a Document Type: Article |
|
Times cited : (20)
|
|
References (0)
|
